Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13636515 | 0.82 | ALDH1A1 (0.34) | CNR2ALDH1A1 | |
| SCHEMBL16385622 | 0.82 | CNR2 (0.32) | CNR2CYP19A1 | |
| SCHEMBL14491221 | 0.82 | CNR2 (0.32) | CNR2CYP19A1 | |
| SCHEMBL14040417 | 0.82 | CNR2 (0.32) | CNR2CYP19A1 | |
| SCHEMBL97345 | 0.82 | CNR2 (0.32) | CNR2CYP19A1 | |
| SCHEMBL4994429 | 0.81 | HSP90AA1 (0.32) | HSP90AA1CNR2 | |
| SCHEMBL4995636 | 0.81 | CNR2 (0.32) | CNR2 | |
| SCHEMBL27816439 | 0.79 | HSP90AA1 (0.33) | HSP90AA1CNR2CYP19A1 | |
| SCHEMBL16358450 | 0.78 | CNR2 (0.30) | CNR2 | |
| SCHEMBL17068030 | 0.78 | SLC6A3 (0.31) | HSP90AA1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1270553-B1 | Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive resin composition | JSR CORP (JP) | 2009-11-18 | — | — | EP | disclosed |
| US-7217492-B2 | Onium salt compound and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2007-05-15 | — | — | US | disclosed |
| CN-1916760-A | Acid generator, sulfonic acid derivative and radiation-sensitive resin composition | JSR CORP (JP) | 2007-02-21 | — | — | CN | disclosed |
| CN-1276303-C | Acid generator and radiation-sensitive resin composition | JSR CORP (JP) | 2006-09-20 | — | — | CN | disclosed |
| US-6908722-B2 | Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2005-06-21 | — | — | US | disclosed |
| US-20050053861-A1 | Onium salt compound and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2005-03-10 | — | — | US | disclosed |
| CN-1432873-A | Acid generator, sulfonic acid derivative and radiation-sensitive resin composition | JSR CORP (JP) | 2003-07-30 | — | — | CN | disclosed |
| US-20030113658-A1 | Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1270553-A2 | Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive resin composition | JSR Corporation (JP) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113658-A1 | Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive resin composition | ASIC1, PFAS, RARA | HSP90AA1 377/4885CNR2 1899/4885ALDH1A1 1216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.